Physician profile
Abigail Debusk
NPI 1154613768
$14,750.15
in general payments reported to CMS, 2019-2025
18 companies · $542 in 2025
The $542 reported for 2025 was more than what 84% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,717 · 2020: $4,738 · 2021: $1,001 · 2022: $1,118 · 2023: $1,183 · 2024: $1,451 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,700 · Food and Beverage: $441 · Education: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,700.00 |
| Food and Beverage | $441.00 |
| Education | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 110 LLC | $13,300.00 | 2019-2025 | |
| Radius Health, INC. | $481.26 | 2019-2025 | Tymlos |
| Amgen INC. | $212.42 | 2019-2025 | Evenity, Prolia |
| Pacira Therapeutics, INC. | $196.05 | 2019-2021 | |
| Depuy Synthes Sales INC. | $104.61 | 2019-2023 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $93.64 | 2020-2024 | Iovera, Exparel, Zilretta |
| Bioventus LLC | $62.33 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $61.80 | 2025 | |
| Smith+Nephew, INC. | $42.41 | 2023 | Journey II |
| Hikma Pharmaceuticals USA | $35.00 | 2024 | Kloxxado |
| Orthofix Medical, INC. | $33.70 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $24.52 | 2020 | |
| Avanos Medical | $21.41 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.87 | 2019 | |
| Si-Bone, INC. | $17.79 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $16.36 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.22 | 2019 | |
| Assertio Therapeutics, INC. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Debusk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.